Royalty Pharma Plc (RPRX)

Royalty Pharma Plc Azioni (RPRX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	6.91%674.14	630.58	621.99	609.29	578.67
	145.92%97.85	39.79	-	-	-
Research and Development	145.92%97.85	39.79	-	-	-
Costs And Expenses	701.06%541.02	67.54	233.61	182.14	368.87
Operating Income/Loss	76.36%133.12	563.04	388.38	427.16	209.80
Nonoperating Income/Loss	45.52%-51.63	-94.78	-32.47	17.06	-119.16
Income/Loss From Equity Method Investments	81.26%4.08	21.76	4.01	15.95	2.69
Income/Loss From Continuing Operations Before Tax	82.60%81.49	468.26	355.91	444.21	90.64
Income Tax Expense/Benefit	-	-	-	-	-
	82.60%81.49	468.26	355.91	444.21	90.64
Attributable To Parent	93.93%17.88	294.69	214.21	288.22	30.18
Available To Common Stockholders, Basic	93.93%17.88	294.69	214.21	288.22	30.18
Attributable To Noncontrolling Interest	63.36%63.60	173.57	141.71	155.99	60.46
Basic Average Shares	1.89%445.06	436.79	-0.48	431.89	423.51
Diluted Average Shares	0.01%556.90	556.84	-2.30	559.61	562.30
Basic Earnings Per Share	94.03%0.04	0.67	0.50	0.67	0.07
Diluted Earnings Per Share	94.03%0.04	0.67	0.50	0.67	0.07
Common Stock Dividends	0.24	0.24	0.22	0.22	0.22